Treatment of Hodgkin Lymphoma: A 50-Year Perspective

George P. Canellos, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Saul A. Rosenberg, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA Jonathan W. Friedberg, James P. Wilmont Cancer Center, University of Rochester, Rochester, NY T. Andrew Lister, Barts Cancer Institute, University of London, London, United Kingdom Vincent T. DeVita, Yale Cancer Center, Yale University School of Medicine, New Haven, CT

Treatment of Hodgkin Lymphoma: A 50-Year Perspective | Litlas